Nursece4less.com

The use of an ACE inhibitor (ACEI) or angiotensin receptor blocker (ARB) as initial therapy is recommended to improve kidney outcomes d. regardless of race or diabetes status. True or False: It may be prudent not to discontinue nadolol therapy abruptly in patients with possible coronary artery disease but it is prudent in patients being treated ... ................
................